Community hub
Recent from talks
Knowledge base stats:
Talk channels stats:
Members stats:
Syneos Health
Syneos Health (formerly InVentiv Health Incorporated and INC Research) is an American company that provides contract research and commercial services to pharmaceutical and biotechnology companies. Based in Morrisville, North Carolina, the company specializes in helping other companies with late-stage clinical trials, but also provides commercial services to market health treatments.
Syneos Health was formed from the merger of InVentiv Health and INC Research, each formed from the consolidation of several companies in the contract research industry. It was listed on Nasdaq until 2023 when the company was taken private by Elliott Investment Management.
Syneos Health was formed from the merger and acquisition of several companies including InVentiv Health and INC Research.
Through InVentiv Health, part of the company's history can be traced back to Snyder Communications, a company founded by Daniel M. Snyder in the 1980s. Snyder Communications had an initial public offering and began trading in the New York Stock Exchange in 1996.[citation needed]
The company formed a healthcare services division, Snyder Healthcare, in 1997 and acquired a number of healthcare related companies that operated or were based in the UK, France, Germany, Ireland, Holland, and Hungary. As of the end of 1998, the company generated more than $320 million in sales per year and employed about 2,800 people in the United States and more than 4,500 in Europe.
In September 1999, Snyder Healthcare was spun off into an independent company called Ventiv Health Inc., with shareholders receiving one share of Ventiv Health Inc. for every two shares of Snyder Communications. Eran Broshy was appointed to serve as chief executive officer and the company began trading on Nasdaq.
In 2005, the company paid $185 million to acquire InChord Communications, a healthcare marketing agency based in Westerville, Ohio. The company subsequently changed its name to InVentiv Health. In 2006, it became listed on the S&P 600 and also acquired for $60 million Adheris Inc. which provides programs for patient persistence and compliance with their prescribed treatment.
In 2010, the company, which at the time was traded on NASDAQ as VTIV, went private with the acquisition by Thomas H. Lee Partners in a deal estimated at $1.1 billion. In January 2018, eight months after INC Research announced plans to acquire it, the firm assumed a new name, Syneos Health, and stock symbol, Nasdaq: SYNH.
Hub AI
Syneos Health AI simulator
(@Syneos Health_simulator)
Syneos Health
Syneos Health (formerly InVentiv Health Incorporated and INC Research) is an American company that provides contract research and commercial services to pharmaceutical and biotechnology companies. Based in Morrisville, North Carolina, the company specializes in helping other companies with late-stage clinical trials, but also provides commercial services to market health treatments.
Syneos Health was formed from the merger of InVentiv Health and INC Research, each formed from the consolidation of several companies in the contract research industry. It was listed on Nasdaq until 2023 when the company was taken private by Elliott Investment Management.
Syneos Health was formed from the merger and acquisition of several companies including InVentiv Health and INC Research.
Through InVentiv Health, part of the company's history can be traced back to Snyder Communications, a company founded by Daniel M. Snyder in the 1980s. Snyder Communications had an initial public offering and began trading in the New York Stock Exchange in 1996.[citation needed]
The company formed a healthcare services division, Snyder Healthcare, in 1997 and acquired a number of healthcare related companies that operated or were based in the UK, France, Germany, Ireland, Holland, and Hungary. As of the end of 1998, the company generated more than $320 million in sales per year and employed about 2,800 people in the United States and more than 4,500 in Europe.
In September 1999, Snyder Healthcare was spun off into an independent company called Ventiv Health Inc., with shareholders receiving one share of Ventiv Health Inc. for every two shares of Snyder Communications. Eran Broshy was appointed to serve as chief executive officer and the company began trading on Nasdaq.
In 2005, the company paid $185 million to acquire InChord Communications, a healthcare marketing agency based in Westerville, Ohio. The company subsequently changed its name to InVentiv Health. In 2006, it became listed on the S&P 600 and also acquired for $60 million Adheris Inc. which provides programs for patient persistence and compliance with their prescribed treatment.
In 2010, the company, which at the time was traded on NASDAQ as VTIV, went private with the acquisition by Thomas H. Lee Partners in a deal estimated at $1.1 billion. In January 2018, eight months after INC Research announced plans to acquire it, the firm assumed a new name, Syneos Health, and stock symbol, Nasdaq: SYNH.